Medicines and Healthcare Products Regulatory Agency (MHRA)
Friday, 18 February, 2011
The MHRA is undertaking a review of UK medicines legislation. As part of this review, it has been looking at the provisions which relate to the product licences of right (PLR) regime and homeopathy.
The MHRA has already written directly to the main organisations and representative bodies informally to seek their views on its initial thinking in this area. It is now writing more widely to seek further views about the likely regulatory impact and any implications not so far identified, again on an informal basis.
